New IPO filings include Adaptive, Morphic

By Mary Romeo, Staff Writer | May 31, 2019 | 8:36 PM GMT

Immunosequencing company Adaptive and integrin company Morphic each filed for IPOs on NASDAQ Thursday, while antipsychotic therapy developer Karuna revealed details of its planned listing on the exchange on Friday.

Adaptive Biotechnologies Corp. (Seattle, Wash.) proposed to raise up to $230 million in an IPO underwritten by Goldman Sachs, J.P. Morgan, BofA